TAKHZYRO 150 mg, Injektionslösung in einer Fertigspritze

7680681780021 CH-68178 Injektionslösung
TAKHZYRO 150 mg, Injektionslösung in einer Fertigspritze
TAKHZYRO 150 mg, Injektionslösung in einer Fertigspritze
TAKHZYRO 150 mg, Injektionslösung in einer Fertigspritze
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Fertigspritze(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
26/03/2025
Patient information leaflet
Français
26/03/2025
Patient information leaflet
Italien
26/03/2025
Summary of Product Characteristics
Allemand
19/08/2024
Summary of Product Characteristics
Français
19/08/2024
Summary of Product Characteristics
Italien
19/08/2024

Detailed composition

Substance Quantity Type Category
(N/A)
150.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
3.46 MG Substance HBESI

Authorization holder

Takeda Pharma AG

8152 Opfikon

Authorization information

Swissmedic authorization number
68178
Drug name
TAKHZYRO, Injektionslösung in einer Fertigspritze
Galenic form
INLFS
ATC Code
B06AC05
Authorization status
Z
Dispensing category
B
First authorization
05/11/2020
Authorization expiration date
31/12/9999
IT Number
02.99.0.
Domain
Human medicine
Field of application
Langzeitprophylaxe von Attacken des hereditären Angioödems

Package details

Description (FR)
TAKHZYRO sol inj 150 mg/ml seringue préremplie
Description (DE)
TAKHZYRO Inj Lös 150 mg/ml Fertigspritze
Market launch
11/04/2024
Narcotic (BTM)
No

Other package sizes (1)

TAKHZYRO sol inj 300 mg/2ml seringue préremplie
1 FESP
GTIN: 7680681780014
View